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Background: Ovarian cancer is predominant of epithelial cell origin and often present at an advanced stage with
poor prognosis. Most animal models of ovarian carcinoma yield thecal/granulose cell tumors, rather than
adenocarcinomas. The best reported induction rate of adenocarcinoma in rats is 10-45% by an ovarian implantation
of 7, 12-dimethylbenz[a]anthracene (DMBA) coated silk suture. We provided an improved procedure to construct
the model by the ovarian implantation of DMBA-coated cloth strip.
Methods: A sterile suture (as S group) or a piece of cloth strip (as CS group) was soaked in DMBA before ovarian
implantation in Wistar rats. Tumor size, incidence rate and pathological type were analyzed.
Results: Ovarian tumors in rats of CS group were first noted at 16 wk post implantation and reached a cumulative
incidence of 75% (96/128) at 32 wk, while the tumor incidence rate in S group at 32 wk was only 46.25% (37/80).
The tumor size in CS group (3.63 ± 0.89 cm) was larger than that of S group (2.44 ± 1.89 cm) (P< 0.05). In CS group,
there were only two types of tumor formed: adenocarcinoma (90/96) and sarcoma (6/96). While in S group, there
were different types, including adenocarcinoma (21/37), squamous carcinoma (3/37), granulosa cell tumor (3/37),
sarcoma (4/37), undifferentiated carcinoma with no adeno character (2/37), benign ovarian tumor (2/37), and
malignant teratoma (1/37).
Conclusion: The model in our study yields much higher incidence and specificity of epithelial derived tumors and
showed histological similarities to human ovarian cancers, which would be more suitable for therapeutic research.
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Epithelial ovarian cancer is a leading cause of female
cancer mortality in the world [1]. In contrast to other
women-specific cancers, like breast and uterine carcin-
omas, where death rates have fallen in recent years,
ovarian cancer cure rates have remained relatively un-
changed over the past two decades [2]. Ovarian adeno-
carcinomas account for 85-90% of all cancers of the
ovary [3]. Effective detection and treatment of ovarian* Correspondence: xucongjian@gmail.com
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reproduction in any medium, provided the orcancer remains a significant clinical challenge. The
exactly initiating cell population for epithelial ovarian
carcinoma (EOC) remains to be defined. Different evi-
dences have suggested that EOC originate from the
ovarian surface epithelium, inclusion cysts lined [4-7] or
alternatively, the fallopian tube epithelium [8] or compo-
nents of the secondary Müllerian system, including the
epithelial cells of the rete ovarii, paraovarian/ paratubal
cysts, endosalpingiosis, endometriosis or endomucinosis
[9-13].
Because the results of ovarian carcinoma treatment
are still far from optimal, animal models are still needed
to study the human EOC. Even though spontaneous
ovarian tumors in rodents have been reported [14], the
paucity of these cases precludes their use in modeling
ovarian cancer. Therefore, much effort has been put intoLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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One such model involves the use of the carcinogen,
7, 12-dimethylbenz[a]anthracene (DMBA), a polycyclic
aromatic hydrocarbon that induces carcinogenic muta-
tions by forming DNA adducts [15]. Incidence of ovarian
adenocarcinoma induction by DMBA varies between
10 to 45% [16,17], which probably due to the strain
difference of rat employed, the chemical form of the
DMBA utilized and the route of drug administrated in
those studies.
Direct implantation of carcinogen appears to be crit-
ical as a single intragastric instillation or intravenous
injection of DMBA in mice yields a comparable total
tumor incidence, even though virtually most of the
tumor exhibited a stromal tumor histology [18]. The
traditional drug-containing silk suture implants would
inevitably damage the stroma of ovary, leading to the
diverse of pathological types of ovarian tumors in
addition to epithelial tumors, such as sarcoma, granu-
lar cell tumor, etc. We report here that 75% tumor
incidence at the end of 32 wk and 93.75% (90/96) of
all tumors diagnosed as adenocarcinoma by implant-
ing a piece of cloth strip soaked with high purity
DMBA onto the surface of Wistar rat ovary. To our
knowledge, this is the first report to use a cloth strip
embedding to the surface of ovary to induce ovarian
cancer.Figure 1 Operation procedure for animals. A: S group. B: CS group. DM
of cloth strip was immersed in the melted DMBA; sutures contained appro
cloth strip contained approximately 1.5 mg of the carcinogen on average,
intraperitoneal injection of chloral hydrate at 50 mg/kg. Then both ovaries
(A) or a DMBA-coated cloth strip (CS group, 128 rats) (B) was then inserted
substance. The arrow referred to the ovary of rat.Material and methods
Tumor induction procedures and evaluation
Five-week-old female Wistar rats (purchased from the
Experimental Animal Center, Chinese Academy of Sci-
ence, SYXK (shanghai) 2004–0011) were housed five per
cage and acclimated to the animal room for one wk be-
fore surgery and received food and tap water ad libitum.
The room was controlled for a constant temperature
(22 ± 2°C) and relative humidity (50± 20%) with a 12 h
light/dark cycle. 7,12-dimethylbenz(a)anthracene (DMBA)
(Sigma Chemical Co, St Louis, MO) was heated to 124°C,
which is the fusion point of the carcinogen. A central por-
tion of 3–0 silk suture or a piece of cloth strip
(0.5 cm×0.5 cm) was immersed in the melted DMBA.
The sutures contained approximately 1 mg per centimeter
of the carcinogen on average and the cloth strip contained
approximately 1.5 mg of the carcinogen on average, as
calibrated by a micro-chemical balance. Rats were
anesthetized by intraperitoneal injection of chloral hy-
drate (Shanghai No.1 Biochemical & Pharmaceutical Co,
Shanghai, China) at 50 mg/kg. Then both ovaries were
surgically exposed, and a DMBA-coated cloth strip
(CS group, 128 rats) or a DMBA-coated suture, as a control
group (S group, 80 rats) was then packed or inserted into
both ovaries and closed with the surround fatty substance
(Figure 1A and 1B). An antibiotic (105 units of benzylpe-
nicillin potassium) was administered intraperitoneally forBA was heated to 124°C. A central portion of 3–0 silk suture or a piece
ximately 1 mg per centimeter of the carcinogen on average and each
as calibrated by a micro-chemical balance. Rats were anesthetized by
were surgically exposed, and a DMBA-coated suture (S group, 80 rats)
or packed into both ovaries and closed with the surrounding fatty
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was closed. Tumor number, size and volume were deter-
mined weekly after the first operation in both groups by
palpating the abdominal wall of rat.
This study was performed in strict accordance with
the recommendations in the Guide for the Care and Use
of Laboratory Animals of the National Science and
Technology Committee. All protocols were approved by
the Biomedical Research Ethics Committee of Shanghai
Institute for Biological Science of Chinese Academy of
Sciences. Every effort was made to minimize suffering.
Preparation and analysis of tissues and histology
All rats were euthanized by CO2 inhalation followed by
cervical dislocation, necropsied and examined for gross
abnormalities. Pathologically altered organs, entire re-
productive tracts and representative specimens of multiple
organs and tissues, including the brain, lung, liver, kidney,
spleen, pancreas and intestine were removed at necropsy,
fixed in 10% (v/v) neutral buffered formalin overnight,
transferred to 70% ethanol and paraffin-embedded. In rats
with evident tumor, specimens of the tumor tissue were
also excised, snap frozen in liquid N2 and stored at −80°C.
For histological analysis, 5 μm formalin fixed paraffin em-
bedded tissue sections were cut for hematoxylin and eosin
stain (H&E staining). Histopathological analysis was per-
formed by a pathologist with expertise in human and mur-
ine malignancies. The tumors were subtyped according to
the histologic characteristics of neoplastic cells (Table 1)
and the results of immunostain.
Immunohistochemistry
Paraffin-embedded sections for immunohistochemistry
were dewaxed, rehydrated and processed for antigen
unmasking by heating to near boiling in citrate buffer
(0.01 M, pH 6.0, 30 min) in a microwave oven, then
allowed to cool for 20 min. Following this and all subse-
quent incubations except for the blocking serum, the slidesTable 1 Histologic subtyping of DMBA-induced ovarian carcin
Tumor subtypes Histolo
Adenocarcinoma Serous carcinoma An ade
Endometrioid carcinoma An ade
or occa
clear cell carcinoma An ade
mucinous carcinoma An ade
Granulosa cell tumor A neop
Squamous carcinoma A carci
Sarcoma A neop
Malignant teratoma Teratom
Undifferentiated carcinoma A carci
Benign ovarian tumor All tumwere washed in phosphate-buffered saline (PBS, 3 × 5 min).
Endogenous peroxidase activity was blocked by hydrogen
peroxide incubation (0.3% in methanol) for 5 min. After
incubation for 30 min in blocking serum (diluted 1:50 in
PBS) appropriate to each secondary antibody, the slides
were incubated with primary antibody at 4°C overnight
(Primary antibodies were omitted as negative controls.)
The primary antibodies used were as follows: polyclonal
anti-rat Pan-CK (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), polyclonal anti-rat inhibin A (Santa Cruz Bio-
technology, Santa Cruz, CA, USA),and polyclonal anti-rat
vimentin (Abcam, ). Detection of primary antibody pro-
ceeded with the binding of biotinylated secondary antibody
(diluted 1:200 for 10 min at room temperature) followed
by avidin-biotin peroxidase complex (Vectastain Elite,
Vector Laboratories, Burlingame, CA) and diaminobenzi-
dine (DAB) chromagen substrate. Dark brown structures
indicated positive immunostaining.
Statistical analysis
The comparison of distribution of variables between two
groups was made using the t-test (SPSS Statistics v13.0,
Chicago, IL), with significance set at a P value of less
than 0.05.
Results
Incidence of ovarian cancers
Thirty-two wk post DMBA treatment, rats in CS group
had developed significantly more advanced tumors (larger
ovarian tumors) compared with that of S group. On an
average of 32 wk post DMBA treatment, 75% of the rats in
CS group (96/128) had developed tumors; whereas only
46.25% (37/80) of the rats in the S group had developed
tumors (P< 0.001). Tumors in both groups were mainly
solid in structure, although a few tumors had a cystic cav-
ity containing an abscess; some were intraperitoneal
spread or seeding of tumor, with or without ascites. As
shown in Figure 2.omas in rats
gic features
nocarcinoma characterized by a pattern of papillae with cellular budding
nocarcinoma composed of simple or pseudostratified epithelial cells,
sionally with squamous differentiation
nocarcinoma mainly composed of hobnail cells
nocarcinoma composed of endocervical-like and intestinal type cells
lasm composed of granulosa cells
noma composed of squamous epithelial cells
lasm composed of malignant nonepithelial cells
a with any malignant contents
noma with no Specifically differentiated cells
ors without malignant characters
Figure 2 The incidence of ovarian cancer of DMBA-treated rats and representative images of the tumors formed. Tumors were detected
by palpating the abdominal wall of rats once a week for a total of 32 weeks to monitor tumor progression and validated by a histological
examination. Open circles, rats of the S group; closed circles, rats of the CS group (A). Tumors were usually a single invasive nodule (B, C), some
were intraperitoneal spread or seeding of tumor (D), with or without ascites. Arrows refers to the tumor.
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Morphologically, rats with tumors had an enlarged
abdomen. The tumors presented as large masses with
reddish color from the ovaries on both sides, and ag-
gressively invaded surrounding organs including theFigure 3 Boxplots showing the tumor size between two groups. The
(2.44 ± 1.89 cm) (P< 0.05), which was measured by counting the greatest d
the outlier value of tumor size in the S group, referred to size 7.3 and 6.3 cspleen, intestine, kidney, and uterus, including some
with bloody ascites. The mean greatest dimension of
the tumors in CS group (3.63 ± 0.89 cm) was larger
than that of S group (2.44 ± 1.89 cm) (*P < 0.05)
(Figure 3).tumor size in CS group (3.63 ± 0.89 cm) was larger than that of S group
imension of the tumors. The number 18 and 19 in the figure indicate
m, respectively.
Figure 4 Histological distribution of DMBA-induced carcinoma in two groups of rats. In CS group (A), tumor histology included two types
only: adenocarcinoma (90/96) and sarcoma (6/96). While in S group (B), tumor histology was distributed as adenocarcinoma (21/37), squamous
carcinoma (3/37), granulosa cell tumor (3/37), sarcoma (4/37), undifferentiated carcinoma with no adeno character (2/37), benign ovarian tumor
(2/37), and one malignant teratoma.
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The majority of tumors in both groups were adenocar-
cinoma. The adenocarcinoma could be categorized as a
mixed carcinoma, in which the lining epithelial cellsFigure 5 Histopathology of ovarian tumors in two groups of rats. For
origin of the respective tumor and analysed in a blinded fashion by a patholo
sarcoma (B), squamous carcinoma (C), and granulosa cell tumor (D). Adenoca
which are separated by Lumina. The nuclear/cytoplasmic ratio is high in these
and large plump nuclei with prominent nucleoli. Sarcoma cells are arranged i
squamous cell differentiation with marked keratinization are observed in squa
granulosa cells of normal follicles and numerous mitosis suggested a rapid grwere composed of flattened or cuboidal cells resembling
ovarian surface epithelium, hobnail cells, and columnar
cells, often with pseudostratified nuclei. Histologically,
93.75% (90/96) of the ovarian tumors in CS group aremalin-fixed tumors were sectioned and stained to determine cellular
gist. Representative tumor samples are shown as adenocarcinoma (A),
rcinoma cells are arranged with glandular structures in back-to-back nests
cells. The nucleus shows obvious pleomorphism, granular chromatin,
n bundles and streams and are in an overall spindle shape. Multifocal
mous carcinoma. The tumor cells were microscopically similar to
owth in granulosa cell tumor. (H & E stain, 200×).
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typical features of ovarian sarcomas (Figure 4A). While
in S group, the histological type of induced tumor
included: adenocarcinoma (21/37), squamous carcinoma
(3/37), granulosa cell tumor (3/37), sarcoma (4/37), un-
differentiated carcinoma with no adeno character (2/37),
benign ovarian tumor (2/37), and malignant teratoma
(1/37) (Figure 4B). Representative and typical tumor
samples are shown as adenocarcinoma, sarcoma, squa-
mous carcinoma, and granulosa cell tumor in Figure 5.
Immunohistochemistry of induced tumors
To confirm histologic observations, we employed a
number of immunohistochemical reagents for epithelial,
grunulosa or mesenchymal cell types, such as pan-CK,
vimentin and inhibin A (Figure 6). In adenocarcinoma,
pan-CK staining of epithelial cells was most often diffuse
but also appeared as localized to a luminal boundary.
Epithelial cell staining of vimentin appeared as peri-
nuclear, polar, or was absent from epithelial cells in moreFigure 6 Immunohistochemical stain of pan-CK, vimentin and inhibin
adenocarcinoma, (B) clear cell adenocarcinoma(C) endometroid adenocarc
sarcoma. (200×). Vimentin was expressed in the stroma of (E) serous adeno
adenocarcinoma, but in (H) sarcoma cancer cell. (200×). Inhibin A was stron
adenocarcinoma, (K) endometroid adenocarcinoma, and (M) granulosa celdifferentiated ductal structures and present only in the
surrounding stroma. Inhibin A was strongly expressed in
adenocarcinoma and weekly in sarcoma. There was no
staining in the sarcoma cells for pan-CK while vimentin
were positive.
Discussion
In past, the DMBA treatment does not always successfully
produce ovarian carcinoma with the rate of incidence at
approximately 50% [19]. To date, a lot of reports available
on overall DMBA-induced carcinoma in mice or rat have
shown reproducible ovarian neoplasms with different de-
livery methods (gavage versus coated suture), dosage,
length of exposure, and length of time before collection of
tissues. In one study, C57BL6 mice received daily doses of
DMBA by gavage for 3 wk; 71% of animals developed
granulosa cell tumors after one year [20]. In another study,
mice of a C57BL6; FVB/NCr background received a
weekly dose of DMBA by gavage for 6 wk; 6 months after
treatment, 27.3% (12/44) of mice developed ovarianA in rat ovarian tumor. Pan-CK was expressed in (A) serous
inoma, and (N) normal ovarian surface epithelium but not in (D)
carcinoma, (F) clear cell adenocarcinoma and (G) endometroid
gly expressed in (I) serous adenocarcinoma, (J) clear cell
l of normal rat ovarian tissue, but weakly in (L) sarcoma. (200×).
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More recently, a study assessing the incidence of cancers
in mice with a P53 (p53Ala135Val/wt) mutation found that
80% of mice that received implants of DMBA-coated su-
ture into their ovaries developed ovarian tumors, of which
50% were adenocarcinomas when evaluated 3 months
after implantation [22].
Generally, traditional immunohistochemical markers
used for the distinction of epithelial, stromal and granu-
losa ovarian tumor, such as CK, vimentin and inhibin A
can be useful, and sometimes, they may show overlap-
ping patterns of expression [23,24]. For example, vimen-
tin could be immunostained in mucinous tumor, serous
tumor, and low-grade endometrioid tumor [25-27]; in-
hibin A could be strongly expressed in epithelial ovarian
cancer and other types of ovarian malignancies [25,26].
In our study, we determined the subtype of induced
ovarian cancer by histologic observations in combination
with immunohistochemistry. CK was expressed in the
cancer cell of adenocarcinoma and normal ovarian sur-
face epithelium but not in sarcoma and stromal. Al-
though inhibin A was thought to be the specific marker
of grunulosa cell, we detected it in the most of adenocar-
cinoma and some sarcoma cells in our induced tumors.
This may due to some biological differences between the
ovarian cancer of rat and human. Further investigations
are required to address the discrepancies.
Compared with the ovaries of human beings, spontan-
eous development of epithelial neoplasms is rare in the
ovaries of rodents [27,28]. One postulated reason for
such low incidence is that the rat ovary is completely
enveloped by a membranous pouch, which protects the
surface epithelium against the effects of local carcino-
gens [29]. In our study, as shown in Figure 4, most of
ovarian tumors induced in the embedded cloth strip
group are adenocarcinoma and comfirmed by immuno-
histochemistry (Figure 6) while the silk suture group
contained quite a lot of non-epithelial type tumors. The
distinctly different outcome of two groups may due to
the procedure during operation. In CS group, we max-
imally kept the inner part of ovaries uninjured by only
dissecting their membranous pouch and let the surface
cell exposed to drugs. While in S group, we inevitably
injured the deep tissue of the ovaries when inserting the
DMBA-coated suture by a needle to allow the drug
penetrate into the tissues besides surface. Our results
also provided further evidence that the origin of ovarian
epithelial cancer derived from ovarian surface cell, and
other types of cancer may originate from middle layer of
ovary.
Intriguingly, the tumor size in our CS group had a lower
standard deviation (S.D.) value than that of S group (0.89
vs. 1.89) (Figure 3). Thus, the cloth strip model generates
a more homogeneous ovarian epithelial cancer model. Itshould provide a more suitable animal model for the re-
search of ovarian cancer than any chemical-induced
model reported previously.
Conclusions
In summary, the results of this study indicate that the
DMBA cloth strip model in rat yields high incidence and
specificity of epithelial derived tumors histologically simi-
lar to human EOC and should be suitable for testing pre-
ventive or therapeutic agents for EOC.
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